Alembic Pharmaceuticals Limited has been recognized by the Asia Book of Records for conducting one of the largest blood pressure screening initiatives in the region, screening 40,468 patients over a two-week period. The nationwide effort brought together 2,174 doctors across India, united by a shared commitment to advancing community health.
The initiative reflects Alembic’s ongoing dedication to preventive healthcare, offering citizens across the country easy access to vital health checks that can help detect hypertension early and encourage timely medical intervention. Blood pressure, often called a “silent” risk factor for cardiovascular disease, remains a significant public health concern in India, making large-scale screening drives like this one especially valuable.
Speaking on the achievement, an Alembic spokesperson expressed pride in the collective effort of the medical community, noting that the milestone was made possible only through the participation and dedication of doctors nationwide.
Alembic Pharmaceuticals remains committed to initiatives that promote accessible, preventive healthcare for communities across India.
Written by: Arundhuti Chatterjee
Graphics by: Pramit Hazra
